Abstract
Hallucinogens are drugs that alter perception of reality. In high-enough doses, these psychedelic or psychomimetic drugs can induce illusions, hallucinations, or delusions. The hallucinogenic state is characterized by heightened awareness of sensory input, a sense of a divided self, and feelings not experienced outside of dreams or religious experiences. Most hallucinogens are plant alkaloids and function as 5-HT2A receptor agonists. Hallucinogens can be divided into indolylalkylamines and phenylalkylamines. This chapter encompasses the history, synthesis, drug abuse patterns, pharmacology, metabolism, detection and analysis, and toxicological interpretation of classic hallucinogenic compounds, including phencyclidine (PCP), lysergic acid diethylamide (LSD), mescaline, psilocybin, and ketamine. More recently, synthetic analogs have also emerged in the illicit drug market as novel psychoactive substances, including analogs of PCP, mescaline (2C and NBOMe types), and ketamine. While PCP may be considered a dissociative anesthetic and ketamine is used as another anesthetic, they are abused for their hallucinogenic properties and are therefore discussed in detail in this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Further Reading
Annual Medical Examiner Data 1993 (1995) Data from the Drug Abuse Warning Network, Statistical Series I Number 13-B, DHHS Publication No. (SMA) 95-3019. U.S. Dept. of Health and Human Services, Substance Abuse and Mental Health Services Administration, Rockville, MD
Aronow R, Miceli JN, Done AK (1978) Clinical observations during phencyclidine intoxication and treatment based on ion-trapping. In: Petersen RC, Stillman RC (eds) Phencyclidine (PCP) abuse: an appraisal (Research Monograph Series #21). National Institute on Drug Abuse, Rockville, MD, pp 218–228
Axelrod J, Brady RO, Witkop B, Evarts EV (1956) Metabolism of lysergic acid diethylamide. Nature 178:143–144
Bailey DN, Shaw RF, Guba JJ (1978) Phencyclidine abuse: plasma levels and clinical findings in casual users and in phencyclidine-related deaths. J Anal Toxicol 2:233–238
Baselt RC (2020) Disposition of toxic drugs and chemicals in man, 12th edn. Biomedical Publications, Seal Beach, CA
Bertron JL, Seto M, Linsley CW (2018) DARK classics in chemical neuroscience: phencyclidine (PCP). ACS Chem Neurosci 9:2459–2474
Bey T (2007) Phencyclidine intoxication and adverse effects: a clinical and pharmacological review of an illicit drug. Cal J Emerg Med 8(1):9–14
Budd RD, Lindstrom DM (1983) Characteristics of victims of PCP-related deaths in Los Angeles County. J Toxicol Clin Toxicol 19:997–1004
Burns RS, Lerner SE (1978) Causes of phencyclidine-related deaths. Clin Toxicol 12(4):463–481
Caplan YH, Orloff KG, Thompson BC, Fisher RS (1979) Detection of phencyclidine in medical examiner’s cases. J Anal Toxicol 3:47–52
Cassels BK, Sáez-Briones P (2018) DARK classics in chemical neuroscience: mescaline. ACS Chem Neurosci 9:2448–2458
Coney LD, Maier LJ, Ferris JA, Winstock AR, Barratt MJ (2017) Genie in a blotter: a comparative study of LSD and LSD analogues’ effects and user profile. Hum Psychopharmacol Clin Exp 32:e2599
Cook CE, Brine DR, Jeffcoat AR, Hill JM, Wall ME (1982) Phencyclidine disposition after intravenous and oral doses. Clin Pharmacol Ther 31:625–634
Cook CE, Brine DR, Quin GD, Perez-Reyes M, DiGuiseppi SR (1982) Phencyclidine and phenylcyclohexene disposition after smoking phencyclidine. Clin Pharmacol Ther 31:635–641
Coppola M, Mondola R (2012) Methoxetamine: from drug of abuse to rapid-acting antidepressant. Med Hypotheses 79:504–507
Cravey RH, Reed D, Ragle JL (1979) Phencyclidine-related deaths: a report of nine fatal cases. J Anal Toxicol 3:199–201
Dean BV, Stellpflug SJ, Burnett AM, Engebretsen KM (2013) 2C or not 2C: phenethylamine designer drug review. J Med Toxicol 9:172–178
deRoux SJ, Sgarlato A, Marker E (2011) Phencyclidine: a 5-year retrospective review from the New York city medical examiner’s office. J Forensic Sci 56(3):656–659
Domino EF (1980) History and pharmacology of PCP and PCP-related analogs. J Psychedelic Drugs 12(3–4):223–227
Domino SE, Domino LE, Domino EF (1982) Comparison of two- and three-compartment models of phencyclidine in man. Subst Alcohol Actions Misuse 2:205–211
Done AK, Aronow R, Miceli JN (1978) The pharmacokinetics of phencyclidine in overdosage and its treatment (Research Monograph 21). National Institute on Drug Abuse, Rockville, MD, pp 210–217
Ellenhorn MJ, Barceloux DG (1988) Medical toxicology, diagnosis, and treatment of human poisoning. Elsevier Science Publishing Company, Inc., New York, NY
Geiger H, Wurst MG, Daniels RN (2018) DARK classics in chemical neuroscience: psilocybin. ACS Chem Neurosci 9:2438–47.19
Glennon RA (1994) Classical hallucinogens an introductory overview. In: Lin GC, Glennon RA (eds) Hallucinogens: an update (Research Monograph Series, #146). National Institute on Drug Abuse, pp 4–32
Goldberger BA (1993) Lysergic acid diethylamide. AACC Ther Drug Monit Toxicol 14(6):99–100
Brunton LL, Lazo JS, Parker KL (eds) (2006) Goodman & Gilman’s: the pharmacological basis of therapeutics, 11th edn. McGraw-Hill Co., New York, NY
Hollister LE, Thomas CC (ed) (1968) Chemical psychoses. Springfield, IL, pp 17–18
Jenkins AJ (2001) Drug contamination of U.S. paper currency. Forensic Sci Int 121:189–193
Johnson K, Jones S (1990) Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential. Annu Rev Pharmacol Toxicol 30:707–750
Johnston LD, Miech RA, O’Malley PM, Bachman JG, Schulenberg JE, Patrick ME (2018) Monitoring the future national survey results on drug use: 1975–2017: overview, key findings on adolescent drug use. Institute for Social Research, The University of Michigan, Ann Arbor, MI
Karch SB (2009) Karch’s pathology of drug abuse, 4th edn. CRC Press, Boca Raton, FL
Kaufmann KR, Petrucha RA, Pitts FN, Weeks ME (1983) PCP in amniotic fluid and breast milk: case report. J Clin Psychiatry 44:269
Kunsman GW, Levine B, Costantino A, Smith ML (1997) Phencyclidine blood concentrations in DRE cases. J Anal Toxicol 21:498–502
LeBeau MA, Mozayani A (eds) (2001) Drug-facilitated sexual assault: a forensic handbook. Academic Press, London UK, pp 27–147
Liu R (1995) Evaluation of commercial immunoassay kits for effective workplace drug testing. In: Liu R, Goldberger B (eds) Handbook of workplace drug testing. AACC Press, Washington, DC
McCarron MM, Schulze BW, Thompson GA (1981) Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med 10:290–297
McCarron MM, Walberg CB, Soares JR, Gross SJ, Baselt RC (1984) Detection of phencyclidine usage by radioimmunoassay of saliva. J Anal Toxicol 8:197–199
Menzies EL, Hudson SC, Dargan PI, Parkin MC, Wood DM, Kicman AT (2014) Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamine. Drug Test Anal 6:506–515
Moffat AC, Jackson JV, Moss MS, Widdop B (eds) (1986) Phencyclidine. In: Clarke’s isolation and identification of drugs. The Pharmaceutical Press, London, UK, pp 874–876
Moore KA, Sklerov J, Levine B, Jacobs AJ (2001) Urine concentrations of ketamine and norketamine following illegal consumption. J Anal Toxicol 25:583–588
Nichols DE (2018) DARK classics in chemical neuroscience: lysergic acid diethylamide (LSD). ACS Chem Neurosci 9:2331–2343
Noguchi TT, Nakamura GR (1978) Phencyclidine-related deaths in Los Angeles County, 1976. J Forensic Sci 23:503–507
Papac DI, Foltz R (1990) Measurement of lysergic acid diethylamide (LSD) in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry. J Anal Toxicol 14:189–190
Perez-Reyes M, DiGuiseppi S, Brine DR, Smith H, Cook CE (1982) Urine pH and phencyclidine excretion. Clin Pharmacol Ther 32:635–641
Ropero-Miller JD, Goldberger BA (2009) Handbook of workplace drug testing, 2nd edn. AACC Press, Washington, DC
Roth BL, Gibbons S, Arunotayanun W, Huang X-P, Setola V, Treble R, Iversen L (2013) The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor. PLoS One 8:e59334
Saferstein R (1988) Phencyclidine. In: Forensic science handbook, vol II. Prentice Hall, Englewood Cliffs, NJ, pp 101–104
Substance Abuse and Mental Health Services Administration (2013) Drug Abuse Warning Network 2011: National Estimates of Drug-Related Emergency Department Visits. HHS Publication No. SMA 13-4760, DAWN Series D-39. Substance Abuse and Mental Health Services Administration, Rockville, MD
Substance Abuse and Mental Health Services Administration (2018) Results from the 2017 National Survey on Drug Use and Health. NSDUH Series H-53, HHS Publication No. SMA 18-5068. Substance Abuse and Mental Health Services Administration, Rockville, MD
Sunshine I (1989) Phencyclidine. AACC Ther Drug Monit Toxicol 10(7):7–13
Suzuki J, Dekker MA, Valenti ES, Arbelo Cruz FA, Correa AM, Poklis JL, Poklis A (2015) Toxicities associated with NBOMe ingestion—a novel class of potent hallucinogens: a review of the literature. Psychosomatics 56:129–139
U.S. Drug Enforcement Administration (2018) Diversion Control Division: National Forensic Laboratory Information System: NFLIS-Drug 2017 Annual Report. U.S. Drug Enforcement Administration, Springfield, VA
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jenkins, A.J., Gates, M.J. (2020). Hallucinogens and Psychedelics. In: Levine, B.S., KERRIGAN, S. (eds) Principles of Forensic Toxicology. Springer, Cham. https://doi.org/10.1007/978-3-030-42917-1_26
Download citation
DOI: https://doi.org/10.1007/978-3-030-42917-1_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42916-4
Online ISBN: 978-3-030-42917-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)